Apply on Employer Site

BrainChild Bio · 6 hours ago

Process Engineer

Seattle, WA

Full-time

Onsite

Mid, Senior Level

$110K/yr - $125K/yr

4+ years exp

BrainChild Bio is seeking to hire a Process Engineer to add to our growing team. This role will provide critical support to technology transfer, process development, and manufacturing activities of BrainChild programs.

BiotechnologyTherapeutics

Responsibilities

Support clinical manufacturing by leading investigations and troubleshooting activities as needed

Provide on the floor GMP manufacturing support as needed

Support process development teams as the voice of manufacturing during clinical product development

Drive technology transfer of manufacturing processes from development to external CMOs as a key member of cross-functional teams

Summarize data sets to management in order to ensure process changes/drift is understood

Drive and Support the effort to create established batch records, for both development and GMP Manufacturing

Develop and use systems for clinical manufacturing data collection and trending

Support clinical manufacturing by leading investigations, providing input to change controls, and troubleshooting activities as needed

Support process risk assessments as needed to drive further characterization studies and/or Process Control Strategy documents

Qualification

Process developmentGMP experienceCell therapy knowledgeData analysis toolsManufacturing operationsProblem-solvingCommunication skillsTeam collaboration

Required

4-5+ years in life sciences supporting process development or manufacturing process improvement and support activities preferably in cell therapy

Proficiency with life science data analysis and visualization tools and experience communicating technical messages to teams

Ability to travel approximately 15% of the time to support tech transfer activities and ongoing manufacturing

Company

BrainChild Bio

BrainChild Bio develops CAR-T cell therapies for pediatric brain tumors, focusing on DIPG.

Founded in 2023

Seattle, Washington, USA

11-50 employees

https://www.brainchildbio.com

Funding

Current Stage

Early Stage

Total Funding

$0.3M

Key Investors

ScaleReady

2025-01-21Grant· $0.3M

Recent News

Research and Markets

CD276 Targeted Therapies Clinical Trials & Market Opportunity Insight Report 2026 - First CD276 Therapy Approval Anticipated by 2028

2025-10-10

Business Wire

FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors

2025-04-22

Company data provided by crunchbase